Tag: Adcock

IIPRD assists Venus Remedies in Successful Technology Out-licensing of Potentox to Adcock, South Africa

Venus Remedies Ltd. has successfully out-licensed its new generation antibiotic drug Potentox to Adcock Ingram Ltd. in South Africa earlier this year. Potentox is a Fixed Dose Combination (FDC) of Cefepime Hydrochloride & Amikacin Sulphate developed by Venus Remedies Ltd., indicated for treatment of Nosocomial Pneumonia & Febrile Neutropenia and available as dry powder for … Continue reading IIPRD assists Venus Remedies in Successful Technology Out-licensing of Potentox to Adcock, South Africa

Read more »